论文部分内容阅读
据《日本化学》周刊报道,日本最大的中药制造企业津村公司最近已在美国纽约设立办事处,以便在美国市场推销作为食疗添加品的中药。 这家日本公司曾在国内对食疗中药进行临床试验。但这些临床试验的食疗中药要进入美国市场,需由美国食品和药品管理局对其所含成分的标准作出估价。
According to the report of the Japan Chemical Weekly, Tsumura, Japan’s largest manufacturer of traditional Chinese medicines, has recently set up an office in New York, USA, to promote traditional Chinese medicine as a dietary supplement in the US market. The Japanese company had conducted clinical trials of Chinese herbal medicines for therapeutic foods at home. However, in these clinical trials, the therapeutic traditional Chinese medicines have to enter the U.S. market and the U.S. Food and Drug Administration needs to make an assessment of the standards of the ingredients it contains.